{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:38:31Z","timestamp":1790491111658,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,2,28]],"date-time":"2012-02-28T00:00:00Z","timestamp":1330387200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s00535-012-0552-9","type":"journal-article","created":{"date-parts":[[2012,2,27]],"date-time":"2012-02-27T05:07:27Z","timestamp":1330319247000},"page":"924-935","source":"Crossref","is-referenced-by-count":73,"title":["Nrf2 inhibits hepatic iron accumulation and counteracts oxidative stress-induced liver injury in nutritional steatohepatitis"],"prefix":"10.1007","volume":"47","author":[{"given":"Kosuke","family":"Okada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Warabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Horie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsutoshi","family":"Tokushige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiko","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuko","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotoshi","family":"Utsunomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Shoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,28]]},"reference":[{"key":"552_CR1","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1053\/j.gastro.2008.02.077","volume":"134","author":"DM Torres","year":"2008","unstructured":"Torres DM, Harrison SA. Diagnosis and therapy of nonalcoholic steatohepatitis. Gastroenterology. 2008;134:1682\u201398.","journal-title":"Gastroenterology"},{"key":"552_CR2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.22603","volume":"49","author":"R Vuppalanchi","year":"2009","unstructured":"Vuppalanchi R, Naga C. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management. Hepatology. 2009;49:306\u201317.","journal-title":"Hepatology"},{"key":"552_CR3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2001-12926","volume":"21","author":"Y Falch-Ytter","year":"2001","unstructured":"Falch-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis. 2001;21:17\u201326.","journal-title":"Semin Liver Dis"},{"key":"552_CR4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","volume":"129","author":"LA Adams","year":"2005","unstructured":"Adams LA, Lymp JF, Sauver JS, Sanderson SO, Lindor KD, Feldstein A, et al. The natural history of nonalcoholic fatty liver disease: a population based cohort study. Gastroenterology. 2005;129:113\u201321.","journal-title":"Gastroenterology"},{"key":"552_CR5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jhep.2004.11.040","volume":"42","author":"L Malaguarnera","year":"2005","unstructured":"Malaguarnera L, Madeddu R, Palio E, Arena N, Malaguarnera M. Heme oxygenase-1 levels and oxidative stress-related parameters in non-alcoholic fatty liver disease patients. J Hepatol. 2005;42:585\u201391.","journal-title":"J Hepatol"},{"key":"552_CR6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0168-8278(02)00331-8","volume":"38","author":"Y Sumida","year":"2003","unstructured":"Sumida Y, Nakashima T, Yoh T, Furutani M, Hirohama A, Kakisaka Y, et al. Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease. J Hepatol. 2003;38:32\u20138.","journal-title":"J Hepatol"},{"key":"552_CR7","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/hep.22365","volume":"48","author":"K Tomita","year":"2008","unstructured":"Tomita K, Oike Y, Teratani T, Taguchi T, Noguchi M, Suzuki T, et al. Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice. Hepatology. 2008;48:458\u201373.","journal-title":"Hepatology"},{"key":"552_CR8","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1053\/j.gastro.2009.09.058","volume":"138","author":"J Yu","year":"2010","unstructured":"Yu J, Chu ES, Wang R, Wang S, Wu CW, Wong VWS, et al. Heme oxygenase-1 protects against steatohepatitis in both cultured hepatocyte and mice. Gastroenterology. 2010;138:694\u2013704.","journal-title":"Gastroenterology"},{"key":"552_CR9","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1096\/fasebj.11.11.9285483","volume":"11","author":"G Leonarduzz","year":"1997","unstructured":"Leonarduzz G, Scavazza A, Biasi F, Chiarpotto E, Camandola S, Vogel S, et al. The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor beta expression in the macrophages lineage: a link between oxidative injury and fibrosclerosis. FASEB J. 1997;11:851\u20137.","journal-title":"FASEB J"},{"key":"552_CR10","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.21874","volume":"46","author":"N Matsuzawa","year":"2007","unstructured":"Matsuzawa N, Takamura T, Kurita S, Nisu H, Ota T, Ando H, et al. Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Hepatology. 2007;46:1392\u2013403.","journal-title":"Hepatology"},{"key":"552_CR11","doi-asserted-by":"crossref","first-page":"8137","DOI":"10.1128\/MCB.23.22.8137-8151.2003","volume":"23","author":"DD Zhang","year":"2003","unstructured":"Zhang DD, Hannink M. Distinct cysteine in Keap1 are required for Keap1-dependent ubiquitination on Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol Cell Biol. 2003;23:8137\u201351.","journal-title":"Mol Cell Biol"},{"key":"552_CR12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF03401947","volume":"7","author":"MK Kwak","year":"2001","unstructured":"Kwak MK, Itoh K, Yamamoto M, Sutter TR, Kensler TW. Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dithiole-3-thione. Mol Med. 2001;7:135\u201345.","journal-title":"Mol Med"},{"key":"552_CR13","doi-asserted-by":"crossref","first-page":"G735","DOI":"10.1152\/ajpgi.90321.2008","volume":"295","author":"K Okada","year":"2008","unstructured":"Okada K, Shoda J, Taguchi K, Maher JM, Ishizaki K, Inoue Y, et al. Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice. Am J Physiol Gastrointest Liver Physiol. 2008;295:G735\u201347.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"552_CR14","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.bbrc.2009.08.156","volume":"389","author":"K Okada","year":"2009","unstructured":"Okada K, Shoda J, Taguchi K, Maher JM, Ishizaki K, Inoue Y, et al. Nrf2 counteracts cholestatic liver injury via stimulation of hepatic defense systems. Biochem Biophys Res Commun. 2009;389:431\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"552_CR15","doi-asserted-by":"crossref","first-page":"G283","DOI":"10.1152\/ajpgi.00296.2009","volume":"298","author":"H Sugimoto","year":"2010","unstructured":"Sugimoto H, Okada K, Shoda J, Warabi E, Ishige K, Ueda T, et al. Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice. Am J Physiol Gastrointest Liver Physiol. 2010;298:G283\u201394.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"552_CR16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.freeradbiomed.2009.11.007","volume":"48","author":"S Chowdhry","year":"2010","unstructured":"Chowdhry S, Nazmy MH, Meakin PJ, Dinkova-Kostova AT, Walsh SV, Tsujita T, et al. Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis. Free Radic Biol Med. 2010;48:357\u201371.","journal-title":"Free Radic Biol Med"},{"key":"552_CR17","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.taap.2010.03.016","volume":"245","author":"YKJ Zhang","year":"2010","unstructured":"Zhang YKJ, Yeager RL, Tanaka Y, Klaassen CD. Enhanced expression of Nrf2 in mice attenuated the fatty liver produced by a methionine- and choline-deficient diet. Toxicol Appl Pharmacol. 2010;245:326\u201334.","journal-title":"Toxicol Appl Pharmacol"},{"key":"552_CR18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.abb.2011.02.001","volume":"508","author":"N Harada","year":"2011","unstructured":"Harada N, Kanayama M, Maruyama A, Yoshida A, Tazumi K, Hosoya T, et al. Nrf2 regulates ferroportin 1-mediated iron efflux and counteracts lipopolysaccharide-induced ferroportin 1 mRNA suppression in macrophages. Arch Biochem Biophys. 2011;508:101\u20139.","journal-title":"Arch Biochem Biophys"},{"key":"552_CR19","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","volume":"306","author":"E Nemeth","year":"2004","unstructured":"Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306:2090\u20133.","journal-title":"Science"},{"key":"552_CR20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0016-5085(98)70482-2","volume":"114","author":"DK George","year":"1998","unstructured":"George DK, Goldwurm S, Macdonald GA, Cowley LL, Walker NI, Ward PJ, et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology. 1998;114:311\u20138.","journal-title":"Gastroenterology"},{"key":"552_CR21","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.febslet.2006.02.031","volume":"580","author":"Y Shinkai","year":"2006","unstructured":"Shinkai Y, Sumi D, Fukami I, Ishii T, Kumagai Y. Sulforaphane, an activator of Nrf2, suppresses cellular accumulation of arsenic and its cytotoxicity in primary mouse hepatocytes. FEBS Lett. 2006;580:1771\u20134.","journal-title":"FEBS Lett"},{"key":"552_CR22","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0003-2697(67)90113-3","volume":"18","author":"AL Foy","year":"1967","unstructured":"Foy AL, Williams HL, Cortell S, Conrad ME. A modified procedure for the determination of non-heme iron in tissue. Anal Biochem. 1967;18:559\u201363.","journal-title":"Anal Biochem"},{"key":"552_CR23","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jhep.2007.06.018","volume":"47","author":"N Imeryuz","year":"2007","unstructured":"Imeryuz N, Tahan V, Sonsuz A, Eren F, Uraz S, Yuksel M, et al. Iron preloading aggravates nutritional steatohepatitis in rats by increasing apoptotic cell death. J Hepatol. 2007;47:851\u20139.","journal-title":"J Hepatol"},{"key":"552_CR24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12263-010-0184-8","volume":"6","author":"MD Garrick","year":"2011","unstructured":"Garrick MD. Human iron transporters. Genes Nutr. 2011;6:45\u201354.","journal-title":"Genes Nutr"},{"key":"552_CR25","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","volume":"362","author":"AJ Sanyal","year":"2010","unstructured":"Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med. 2010;362:1675\u201385.","journal-title":"N Engl J Med"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-012-0552-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-012-0552-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-012-0552-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T15:02:13Z","timestamp":1561388533000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-012-0552-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,28]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["552"],"URL":"https:\/\/doi.org\/10.1007\/s00535-012-0552-9","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,28]]}}}